CLINICAL TRIALS PROFILE FOR DURAMORPH PF

All Clinical Trials for DURAMORPH PF

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00335517 ↗	Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients	Completed	EKR Therapeutics, Inc	N/A	2006-06-01	The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.
NCT00335517 ↗	Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients	Completed	University of Rochester	N/A	2006-06-01	The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.
NCT00385541 ↗	Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)	Completed	Columbia University	Phase 4	2003-11-01	Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, vomiting, and itching they have with each drug
NCT01298778 ↗	High Pain Intervention in Cesarean Sections	Completed	Wake Forest School of Medicine	N/A	2010-08-01	In previous studies the investigators have seen that the severity of pain one day after cesarean delivery can predict the presence of pain and depression 2 months later. The investigators believe those at risk for severe acute post-partum pain can be identified, and medical interventions can be tailored to manage postoperative pain more effectively.
NCT01298778 ↗	High Pain Intervention in Cesarean Sections	Completed	Wake Forest University Health Sciences	N/A	2010-08-01	In previous studies the investigators have seen that the severity of pain one day after cesarean delivery can predict the presence of pain and depression 2 months later. The investigators believe those at risk for severe acute post-partum pain can be identified, and medical interventions can be tailored to manage postoperative pain more effectively.
NCT01362998 ↗	Epidural Morphine Versus Epidural Fentanyl Infusion Following Cesarean Section	Unknown status	Goodman, Evan, M.D.	N/A	2011-03-01	For post-Cesarean analgesia, the investigators will compare the efficacy of single-shot epidural preservative free morphine with a continuous epidural fentanyl infusion. The investigators will be comparing the patient's pain level and satisfaction with the two techniques, as well as the side effects that the patients experience, such as itching, nausea, back pain and respiratory depression.

Clinical Trial Conditions for DURAMORPH PF

Condition Name

Condition Name for DURAMORPH PF
Intervention	Trials
Pain	9
Cesarean Section	4
Pain, Postoperative	3
Analgesia, Obstetrical	3

Condition MeSH

Condition MeSH for DURAMORPH PF
Intervention	Trials
Pain, Postoperative	10
Post-Dural Puncture Headache	2
Headache	2
Osteoarthritis	2

Clinical Trial Locations for DURAMORPH PF

Trials by Country

Trials by Country for DURAMORPH PF
Location	Trials
United States	63

Trials by US State

Trials by US State for DURAMORPH PF
Location	Trials
New York	11
Ohio	7
Virginia	5
New Jersey	4
Minnesota	4

Clinical Trial Progress for DURAMORPH PF

Clinical Trial Phase

Clinical Trial Phase for DURAMORPH PF
Clinical Trial Phase	Trials
Phase 4	20
Phase 3	2
Phase 2	3

Clinical Trial Status

Clinical Trial Status for DURAMORPH PF
Clinical Trial Phase	Trials
Completed	17
Terminated	7
Unknown status	4

Clinical Trial Sponsors for DURAMORPH PF

Sponsor Name

Sponsor Name for DURAMORPH PF
Sponsor	Trials
Pacira Pharmaceuticals, Inc	3
Virginia Commonwealth University	3
Mayo Clinic	2

Sponsor Type

Sponsor Type for DURAMORPH PF
Sponsor	Trials
Other	37
Industry	6
NIH	2